Science Explorer Back to mapMap
Discussion
Researcher · Framingham State University · United States

Vivek K. Vishnudas

Vivek K. Vishnudas publishes mostly in Molecular Biology, Cancer Research and Spectroscopy, on topics such as Cancer, Hypoxia, and Metabolism, Metabolomics and Mass Spectrometry Studies and Mitochondrial Function and Pathology.

ORCID 0009-0003-1453-1507 OpenAlex
World rank
#5,398,007
of 7,710,434 ranked researchers
Rank in United States
#1,369,133
of 1,627,098
Works
135
Citations
635
Citations per work
4.7
h-index
14
i10-index 15Top 55% in Molecular Biology
Vivek K. Vishnudas

What does Vivek K. Vishnudas research?

Vivek K. Vishnudas's work is mostly in Biochemistry, Genetics and Molecular Biology (58%), Medicine (9%), Chemistry (7%).

Life Sciences: 78 works · 57.7% of their workBiochemistry, Genetics and Molecular Biology: 78 works · 57.7% of their workMolecular Biology: 60 works · 44.6% of their workCancer Research: 18 works · 13.1% of their workEverything else: 31 works · 22.9% of their workPhysical Sciences: 14 works · 10.4% of their workChemistry: 9 works · 6.9% of their workSpectroscopy: 9 works · 6.9% of their workEngineering: 5 works · 3.5% of their workBiomedical Engineering: 5 works · 3.5% of their workHealth Sciences: 12 works · 9.0% of their workMedicine: 12 works · 9.0% of their workOncology: 7 works · 5.5% of their workCardiology and Cardiovascular Medicine: 5 works · 3.5% of their workTHEIR WORKVivek K.Vishnudas135works
Life Sciences58%Physical Sciences10%Health Sciences9%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology7857.7%
  2. Everything else3122.9%
    1. Chemistry96.9%
    2. Engineering53.5%
    1. Medicine129.0%
  1. 1Molecular Biology45% of their works
  2. 2Cancer Research13% of their works
  3. 3Spectroscopy7% of their works
  4. 4Oncology6% of their works
  5. 5Biomedical Engineering4% of their works
  6. 6Cardiology and Cardiovascular Medicine4% of their works

Research topics

Which keywords describe Vivek K. Vishnudas's research?

The keywords of their largest research topics: Mass Spectrometry, Mitochondrial Dysfunction, Oxidative Stress, HIF-1, Warburg Effect, Data Analysis, Metabolomics and Mitochondria.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Mass Spectrometry372 topics
  2. Mitochondrial Dysfunction292 topics
  3. Oxidative Stress292 topics
  4. HIF-1271 topic
  5. Warburg Effect271 topic
  6. Data Analysis221 topic
  7. Metabolomics221 topic
  8. Mitochondria151 topic
  9. Proteomics151 topic
  10. Quantitative Analysis151 topic
  11. Reactive Oxygen Species151 topic
  12. ATP Synthase141 topic
  13. Function141 topic
  14. Metabolism141 topic
  15. Vacuolar ATPases141 topic
  16. Gene Set Enrichment Analysis121 topic
  17. Protein-Protein Interaction Networks121 topic
  18. Molecular Docking91 topic
  19. Virtual Screening91 topic

Where does Vivek K. Vishnudas work?

Vivek K. Vishnudas's main affiliation in the publication record is Framingham State University, United States.

How many publications and citations does Vivek K. Vishnudas have?

OpenAlex counts 135 works and 635 citations for Vivek K. Vishnudas, an h-index of 14, ranking #5,398,007 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Vivek K. Vishnudas. Posts are plain text and can be reported.